Accessibility Experts
Connect for media, speaking, professional opportunities & more.
Filters
Charles Burke
President & CEOFrederik Meijer Gardens & Sculpture Park
Charles Burke champions the intersection of art, culture and nature to build healthy communities—a philosophy he embodies at Meijer Gardens.
C. Michael White, Pharm.D., FCP, FCCP
Head and Distinguished Professor, Department of Pharmacy PracticeUniversity of Connecticut
Dr. White’s research interests are in drug, dietary supplement, and illicit drug safety, quality, and cost
Bruce Armitage
Professor and Co-DirectorCarnegie Mellon University
Bruce Armitage’s current research interests include the use of PNA for sequence-specific recognition of DNA and RNA.
Barry Elkind
Manager, Technology & Venture Development (Head, Molecular Diagnostics)MaRS Innovation
Commercializing life science technologies in the areas of molecular diagnostics, medical devices and therapeutics
Patricia Mokhtarian
Professor, Civil EngineeringGeorgia Tech - COE
Patricia Mokhtarian has specialized in the application of quantitative methods to the study of travel behavior for more than 30 years.
Beth Mineo
Associate Professor, Education; Director, Center for Disabilities StudiesUniversity of Delaware
Prof. Mineo's Research focuses on autism and other communication disorders, particularly language disorders.
Terrence Carolan, MSPT, MBA
Managing Director of Medical Rehabilitation and Aging ServicesCARF International
Terrence Carolan has more than 20 years of experience as a provider, educator, and administrator in the medical rehabilitation field.
Jeffrey P. Cohen, Ph.D.
Kinnard Scholar in Real Estate and ProfessorUniversity of Connecticut
Jeffrey P. Cohen is an expert on transit-oriented development and housing, factors impacting real estate values, and property taxation
Stephen Davies
Professor of Computer ScienceUniversity of Mary Washington
Dr. Davies specializes in computer modeling and simulation.
Dr. Mark Ware
Chief Medical OfficerCanopy Growth
Dr. Ware leads Canopy Growth’s medical division, Spectrum Therapeutics including research towards the development of cannabinoid medicines.